R

Repare Therapeutics
D

RPTX

1.36000
USD
0.04
(3.03%)
Market Closed
Volume
0
EPS
-2
Div Yield
-
P/E
-1
Market Cap
57,814,563
OverviewSignalsIdeasNews
Related Instruments
    A
    ALDX
    -0.07500
    (-1.54%)
    4.79500 USD
    A
    ARCT
    1.010
    (6.52%)
    16.510 USD
    A
    ARWR
    0.310
    (1.59%)
    19.760 USD
    A
    ASND
    3.770
    (2.77%)
    139.880 USD
    B
    BLUE
    -0.87500
    (-10.31%)
    7.61500 USD
    BNTX
    BNTX
    0.420
    (0.37%)
    113.470 USD
    C
    CRSP
    -0.220
    (-0.54%)
    40.500 USD
    E
    EDIT
    -0.06000
    (-4.55%)
    1.26000 USD
    More
News

Title: Repare Therapeutics

Sector: Healthcare
Industry: Biotechnology
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.